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Randall's plaqueMany calciumoxalate (CaOx) kidney stones develop attached to renal papillary sub-epithelial deposits of calcium
phosphate (CaP), called Randall's plaque (RP). Pathogenesis of the plaques is not fully understood. We hypothe-
size that abnormal urinary environment in stone forming kidneys leads to epithelial cells losing their identity and
becoming osteogenic. To test our hypothesismale ratsweremade hyperoxaluric by administration of hydroxy-L-
proline (HLP). After 28 days, rat kidneys were extracted. We performed genome wide analyses of differentially
expressed genes and determined changes consistent with dedifferentiation of epithelial cells into osteogenic
phenotype. Selected molecules were further analyzed using quantitative-PCR and immunohistochemistry.
Genes for runt related transcription factors (RUNX1 and 2), zinc ﬁnger protein Osterix, bonemorphogenetic pro-
teins (BMP2 and 7), bone morphogenetic protein receptor (BMPR2), collagen, osteocalcin, osteonectin, osteo-
pontin (OPN), matrix-gla-protein (MGP), osteoprotegrin (OPG), cadherins, ﬁbronectin (FN) and vimentin
(VIM) were upregulated while those for alkaline phosphatase (ALP) and cytokeratins 10 and 18 were downreg-
ulated. In conclusion, epithelial cells of hyperoxaluric kidneys acquire a number of osteoblastic features but with-
out CaP deposition, perhaps a result of downregulation of ALP and upregulation of OPN and MGP. Plaque
formationmay additionally require localized increases in calcium and phosphate and decrease inmineralization
inhibitory potential.
Published by Elsevier B.V.1. Introduction
Kidney stone formation is a common chronic disease and its lifetime
prevalence is increasing in United States as well as the rest of the world
[1,2]. The increase in stone prevalence is associated with simultaneous
escalation in cost of taking care of patients, which has already reached
over ten billion dollars/year. But this ﬁgure does not include the hidden
costs of nephrolithiasis, the impact on renal functions and quality of life
[3]. New epidemiological studies also provide the evidence that stone
formation is a risk factor for developing hypertension, chronic kidney
disease and end stage renal disease [4–7]. The number of stone episodes
and surgical interventions is highly correlatedwith reduction and loss of
renal function [3]. Obesity, hypertension, diabetes, chronic kidney dis-
ease and metabolic syndrome, all of which are on the rise, are also risk
factors for stone formation in the adult population [5,8]. In the case of
pediatric urolithiasis, analysis of PHIS database showed that stonehosphate; RP, Randall's plaque;
hogenetic protein; BMPR, bone
e; OPN, osteopontin; MGP, ma-
, Immunology and Laboratory
inesville, Florida 32610-0275,patients had signiﬁcantly higher odds of hypertension and obesity
than the controls [9].
Calcium oxalate (CaOx) kidney stones develop attached to Randall's
plaques (RP), subepithelial deposits of calcium phosphate (CaP) on
renal papillary surface, or Randall's plugs, crystal aggregates blocking
the terminal collecting ducts [10–14]. The plaques themselves originate
deep inside the renal interstitium associated with the basement mem-
branes of loops of Henle, collecting ducts or blood vessels [15,16]. Mech-
anisms involved in the initial formation of the RPs are still unclear.
Pathogenesis is generally considered a passive, unregulated physico-
chemical process [17]. In our opinion [18], as well as some others [19]
plaque and stone formation are actively regulated processes similar to
vascular calciﬁcation in the kidneys in which vascular smooth cells
(VSMC) acquire osteogenic phenotype [20–22]. Exposure of VSMC to el-
evated levels of calcium and phosphate triggers osteogenic transforma-
tion of VSMC [23–26]. Transformation involves increased expression of
osteoblast speciﬁc genes and decrease in smooth muscle cell markers
[27,28]. Bone morphogenetic proteins, BMP 2 and BMP 4, and Wnt sig-
naling pathways are activated through up-regulation of transcription
factor, runt-related transcription factor 2 (RUNX2). Cells produce ma-
trix proteins. Reactive oxygen species are likely involved in the VSMC
transformation to osteogenic phenotype by regulating RUNX-2 tran-
scription factor [29,30]. It is our hypothesis that abnormal urinary envi-
ronment such as hyperoxaluria, hypercalciuria and hypocitraturia and
associated oxidative stress, produce speciﬁc changes in the renal
Table 1
The list of forward and reverse primers used for quantitative Real Time PCRdesignedusing
Primer-BLAST (National Center for Biotechnology Information, NCBI, and National Insti-
tute of Health, NIH).
Gene Primer Sequence
Fibronectin (Fn1) Fn1_F 5′-GTGGCTGCCTTCAACTTCTC-3′
Fn1_R 5′-GTGGGTTGCAAACCTTCAAT-3′
Runt-related transcription
factor-2 (Runx2)
Runx2_F 5′-TCCCATCTGCTAGAAGTGTT-3′
Runx2_R 5′-TTAGCCAGCTCACTTTCTTC-3′
Osterix/SP7 Sp7_F 5′-AAGCCATACACTGACCTTTC-3′
Sp7_R 5′-GTGGGTAGTCATTGGCATAG-3′
Bone morphogenetic
protein-2 (Bmp2)
Bmp2_F 5′-ACCAGACTATTGGACACCAG-3′
Bmp2_R 5′-AATCCTCACATGTCTCTTGG-3′
Bone morphogenetic
protein-7 (Bmp7)
Bmp7_F 5′-ATGGCCAACGTGGCAGAGAA-3′
Bmp7_R 5′-CAGCCCAGGTCTCGGAAGCT-3′
Bone morphogenetic
protein receptor,
type II (Bmpr2)
Bmpr2_F 5′-ATAGGCGTGTGCCAAAAATC-3′
Bmpr2_R 5′-GCTAGGGATTCGAGCTTGTG-3′
Cytokeratin 8 or
keratin 8 (Krt8)
Krt8_F 5′-AGCCAGAGTACCAGCCCTAA-3′
Krt8_R 5′-ACAATTGAGTTGGGCATTGGC-3′
Cytokeratin 18 or
keratin 18 (Krt18)
Krt18_F 5′-ATATCCGTGTCCCGCTCTGT-3′
Krt18_R 5′-TCGTTCAGGTCTTGCATGGT-3′
Vimentin (Vim) Vim_F 5′-TTCTCAGCACCACGATGACC-3′
Vim_R 5′-TGCTGAGCTCGTTTCTATCCC-3′
A 
B 
Fig. 1. H&A stained section of a kidney from hyperoxaluric rat on the 28th day of feeding
on hydroxyl-L-proline (HLP). A. Lowmag image showing both cortical andmedullary seg-
ments of the kidney. Calcium oxalate (CaOx) crystal deposits appear as bright spots and
most of them are located in the cortical renal tubules. Original X2.5. B. High magniﬁcation
image showing a glomerulus and tubules with andwithout CaOx crystals. Glomerulus and
tubules without the crystals appear normal. Tubules with crystals are dilated with many
fold increase in their luminal diameter and compressed lining epithelia. Renal interstitium
shows signs of inﬂammation. Original X45.
2001S. Joshi et al. / Biochimica et Biophysica Acta 1852 (2015) 2000–2012epithelial cells. The cells lose their epithelial character and become
osteogenic. We decided to test our hypothesis in a rat model of
hyperoxaluria. Since many genes and pathways are involved we per-
formed genome wide analysis of differentially expressed genes in the
kidneys and determined changes consistent with the dedifferentiation
of epithelial cells into bone producing cells.
We investigated the expression of genes considered to be involved
in epithelial transformation and bonemorphogenesis including runt re-
lated transcription factors (RUNX) [31,32], zinc ﬁnger protein Osterix
[33], bonemorphogenetic proteins (BMP1-7) [34], bonemorphogenetic
protein receptor (BMPR) [35], collagens [36], alkaline phosphatase
(ALP) [37], osteocalcin [31], osteonectin [38], osteopontin (OPN) [39]
matrix-gla-protein (MGP) [21], osteoprotegrin (OPG) [40], cytokeratins
[41], cadherins [42], ﬁbronectin (FN) [43] and vimentin (VIM) [44]. Ep-
ithelial cells express high levels of cytokeratin 8, 10, 18, as well as E-
cadherin, while mesenchymal cells express N-cadherin, ﬁbronectin
and vimentin [45]. BMPs play signiﬁcant role in osteoblast differentia-
tion and interact with BMPRs [46,47]. Collagens are major constituent
of extracellularmatrix [48], control matrix remodeling and are involved
in calciﬁcation [49] including growth of Randall's plaques [50]. ALP is a
membrane associated enzyme and plays critical role in both physiolog-
ical and pathological calciﬁcation [51,52]. RUNX2 also known as core-
binding factor alpha-1 is a key transcription factor associated with
osteoblast differentiation [53,54]. Osterix is a zinc-ﬁnger containing
transcription factor essential for osteoblast differentiation [46]. This re-
port shows the changes that occur in the expressions of thesemolecules
of interest in renal tissues in response to sustained hyperoxaluria and
crystal formation. We discuss how these changes point to a number of
molecular processes that may be involved in the deposition of CaP crys-
tals in the renal interstitium and formation of plaques.
2. Materials and methods
2.1. Animal procedures
The experiments described herein were performed in Sprague-
Dawley rats purchased from Harlan Labs, Inc. The studies were ap-
proved by the University of Florida's IACUC and were conducted in ac-
cordance with the recommendations of the NIH Guide for the Care
and Use of Laboratory Animals. All procedures are detailed in our earlier
publications [55–57]. In brief, two groups of 6 rats each, average weight
of 150 g, were placed in metabolic cages with free access to food andwater. Rats in group 1were fed a normal rat chow diet and given sterile
water. Rats in group 2 were fed the same chow as group 1 rats, but sup-
plemented with 5% (w/w) hydroxy-L-proline (HLP). At the end of day
28, all rats were euthanized and their kidneys removed. From each rat,
one kidney was used for RNA isolation, while the second was placed
in 10% phosphate buffered formalin for histological analyses.
2.2. RNA extraction and differential expression of genes by microarray
analysis
Each rat kidney excised for RNA isolation was surgically separated
into medulla and cortex, then snap frozen in liquid nitrogen and stored
at−80 °C. Total RNA was isolated concurrently from each of the speci-
mens using the RNeasy Mini-Kit (QIAGEN, Valencia, CA) as per the
manufacturer's instructions. Microarray hybridizations were carried
out with each of the RNA specimens using the Illumina™RatRef-12
Fig. 2. Relative gene expression in the cortex andmedulla of kidneys of control andHLP-fed rats. Gene expression of runt related transcription factor-1 and2 (RUNX1andRUNX2), and zinc
ﬁnger protein Osterix/SP7was upregulated in the HLP-fed rats. Genes for alkaline phosphatase were downregulated in both cortex and medulla of the HLP-fed rats.
2002 S. Joshi et al. / Biochimica et Biophysica Acta 1852 (2015) 2000–2012Expression Bead Chip containing N22,000 genes expressed in the rat ge-
nome. Expressed values were determined using the Illumina™ bead
array reader. Allmicroarray data have been depositedwith theGene Ex-
pression Omnibus (GSE36446).
Gene expression data analysis was performed using the Genome
Studio Gene ExpressionModule V1.0. Before the analysis, the individual
signal intensity values retrieved from the microarray probes were log
transformed (using 2 as a base) and normalization was done for all
the individual samples within each study group. After normalizing the
signal intensity values for each of the 36 arrays, the Student's t-test
was used to do a probe-by probe comparison between two groups con-
currently. For each comparison, the fold change (FC) and p-value was
calculated for each gene within each experimental group and volcano
plots were drawn for each comparison. Differential gene expressions
were compared between the cortex and medulla tissues from control
versus HLP-treated rats using Database for Annotation, Visualization of
Integrated Discovery (DAVID) enrichment analysis tool (Bioinformatics
Resources, National Institute of Allergy and Infectious Diseases) for GO:
TERM and KEGG pathway analysis [58,59]. Cluster analysis of genes was
also done for the identiﬁcation of biological processes, cellular compo-
nent, and molecular function ontology.Fig. 3. Relative gene expression in the cortex and medulla of kidneys of control and HLP-fed ra
morphogenetic protein receptor, type 2 (BMPR2) were upregulated in the HLP-fed rats.2.3. Histological examinations
Formalin ﬁxed tissues were embedded in parafﬁn and sectioned to a
thickness of 5-μm. Deparafﬁnization of parafﬁn-embedded slides was
performed by xylene immersion followed by dehydration in ethanol.
Kidney sections were stained with Hematoxylin/Eosin (H&E) and peri-
odic acid-Schiff (PAS). Immunohistochemical staining was performed
using speciﬁc antibodies against VIM, collagen, OPN, MGP, FN and
pancytokeratin antibody AE1/3, a cocktail for a number of cytokeratins
found in epithelial cells. Staining was developed by the addition of di-
aminobenzidine (DAB) substrate (Vector Labs, Burlingame, CA, USA)
and counterstained with hematoxylin. Images were taken using the
Zeiss Axiovert 200 M microscope (Carl Zeiss Microimaging, Inc.,
Thornwood, NY, USA).
2.4. Real time-PCR
Results of microarray analyses were conﬁrmed using RT-PCR of se-
lected genes. cDNA was generated using Invitrogen's SuperScript III
First-Strand Synthesis System (Carlsbad, CA, USA; Cat. # 18080-051),
as described previously [55]. Quantitative real time PCR was carriedts. Gene expression of bone morphogenetic proteins 2 and 7 (BMP2 and BMP7), and bone
Fig. 4. Relative gene expression of cytokeratin 10 (KRT 10), cytokeratin 18 (KRT 18), cytokeratin 8 (KRT 8) and Vimentin (VIM) in the cortex and medulla of HLP treated rats. KRT10 and
KRT18 gene expression was downregulated whereas KRT 8 and VIM were upregulated.
2003S. Joshi et al. / Biochimica et Biophysica Acta 1852 (2015) 2000–2012out to determine themRNA expression of ﬁbronectin1 (Fn1), runt relat-
ed transcription factor-2 (RUNX2), Osterix, bone morphogenetic pro-
teins (BMP2, BMP7), bone morphogenetic protein receptor, Type 2
(BMPr2), cytokeratins (KRT8, KRT18), VIM, OPN, CoL1a1, and ALP in
both renal cortex and medulla. The mRNA of these genes was PCR am-
pliﬁed and detected using the Roche's FastStart High Fidelity PCR Sys-
tem (Indianapolis, IN, USA; Cat. # 03553426001). Housekeeping genes
GAPDH and Actin were used to normalize the expression of the tested
genes. These stable housekeeping or the internal control genes were
used to remove any sampling differences (such as RNA quantity and
quality) in order to identify real gene expression. The forward and re-
verse primers used are listed in Table 1.Fig. 5. Relative gene expression of OPN, Fibronectin (FN1), COL1A1 and COL1A2 in t“cDNA was generated using Invitrogen's SuperScript III First-Strand
Synthesis System (Carlsbad, CA, USA; Cat. # 18080-051). Brieﬂy, 5 μg
of total RNA was added to a 0.5-mL tube with 50 μM Oligo (DT) 20,
10 mM dNTP mix, and DEPC-treated water for a ﬁnal volume of 10 μL.
The sample was incubated at 60 °C for 5 min and then placed on
ice for 1 min. The sample was then added to cDNA Synthesis Mix
[10 × RT buffer (supplied with kit), 25 mMMgCl2, 0.1 M DTT, 40 U/μL
RNase OUT, 200 U/μL SuperScript III RT] and incubated at 50 °C for
50 min. The reaction was terminated by heating at 85 °C for 5 min
followed by chilling on ice. Onemicroliter of Rnase Hwas added to sam-
ples and incubated for 20 min at 37 °C. After incubation, the samples
were ready for use in RT-PCR reaction.”he cortex and medulla of HLP treated rats. Gene expressions were upregulated.
Fig. 6. Real Time PCR of runt related transcription factor-2 (RUNX2), zinc ﬁnger protein Osterix/SP7 and ALP in the cortex andmedulla of the control and HLP fed rats. The statistical anal-
yses were performed using GraphPad Prism version 5 for windows (GraphPad software, La Jolla, CA). P-values were calculated using unpaired T-test. P b 0.05 was considered statistically
signiﬁcant. *Control vs. HLP group (P b 0.05), **Control vs. HLP group (P b 0.005), ***Control vs. HLP group (P b 0.0001).
2004 S. Joshi et al. / Biochimica et Biophysica Acta 1852 (2015) 2000–2012Real timeRT-PCRwas performed using the SYBR®Green PCRmaster
Mix (Cat. # 4309155) and the Applied Biosystems StepOnePlusTM Real
Time PCR systems to determine the gene expression. PCR reactions
were performed in total volume of 20 μL containing 10 μL of SYBR®
Green PCR master Mix, 1 μL of forward and reverse primer each, 4 μL
of cDNA, and 4 1 μL of sterile DD H2O. The reactions were cycled for
950C for 10 min, followed by 40× cycles of 950C for 15 min, 600C (for
RUNX2, SP7, ALP, BMP2, KRT8, VIM,Fn1 and Col1A1) or 550C (for
BMP7, BMPr2) or 650C (for KRT18) or 630C (for OPN) for 1 min.
3. Results
3.1. Histology
HLP administration to male rats produced hyperoxaluria and CaOx
crystal deposition in their kidneys as shown previously [55,56,60].
After 28 days of HLP consumption, urinary excretion of oxalate by therats wasmany folds higher than the controls and extent of crystal depo-
sition ranged from few small crystal aggregates to extensive deposition
of large deposits throughout the kidneys. Even though renal tubules of
all segments of the kidneys, cortex, medulla and papilla, contained
CaOx crystals, the majority of the crystals were seen in the tubular lu-
mens of the distal tubules and collecting ducts of the cortex and outer
medulla (Fig. 1). The tubular segments that contained crystals were di-
lated with many fold increase in lumen diameter. Their lining epitheli-
um appeared damaged. Tubular epithelia were attenuated and focally
sloughed from the tubular basementmembranes. Interstitial inﬂamma-
tion was conspicuous around the tubules containing crystals. Glomeruli
and tubules without crystals appeared normal.
3.2. Microarray analysis
Relative gene expression of runt related transcription factor-1 and 2
(RUNX1 and RUNX2), and zinc ﬁnger protein Osterix/SP7 was greatly
Fig. 7. Real Time PCR of bone morphogenetic proteins 2 (BMP2), bone morphogenetic proteins 7 (BMP7), and bone morphogenetic protein receptor, Type 2 (BMPR2) in the cortex and
medulla of the control and HLP fed rats. The statistical analyses were performed using GraphPad Prism version 5 for windows (GraphPad software, La Jolla, CA). P-values were calculated
using unpaired T-test. P b 0.05 was considered statistically signiﬁcant. *Control vs. HLP group (P b 0.05), **Control vs. HLP group (P b 0.005), ***Control vs. HLP group (P b 0.0001).
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HLP-fed rats compared to the tissues from the control rats (Fig. 2).
Expression of gene for ALP was downregulated (Fig. 2). Relative
gene expression of bone morphogenetic proteins 2 and 7 (BMP2
and BMP7), and bone morphogenetic protein receptor Type 2
(BMPR2) were also upregulated in the kidneys of the HLP-fed rats
(Fig. 3). Relative expression of genes for cytokeratin 10 (KRT 10)
and cytokeratin 18 (KRT 18) were downregulated while that of
cytokeratin 8 (KRT 8) upregulated in both the cortex and medulla
of HLP-treated rat kidneys (Fig. 4). Relative expression of gene
encoding for VIM was also highly upregulated in kidneys of the HLP
treated rats as shown in Fig. 4.
Osteoblast marker genes, encoding for OPN, FN, COL1a1, COL1a2
(Fig. 5), osteocalcin, bone differentiation marker osteonectin (results
not shown) were also upregulated. Similarly there were signiﬁcant in-
creases in gene encoding for MGP (results not shown). Genes for osteo-
blast secreted receptor osteoprotegrin (OPG) and cadherins 1, 10, 16,which are involved in regulating cell adhesion and mobility, were all
downregulated (results not shown).
3.3. Real time PCR
Results ofmicroarray analyseswere conﬁrmed by performing RT-PCR
for selected molecules. Both RUNX2 and Osterix mRNA showed many
fold increases in both the cortex and medulla of the HLP-treated rat kid-
neys (Fig. 6). There was many fold reduction in alkaline phosphatase
mRNA, a very important player in calciﬁcation, in both the cortex andme-
dulla of hyperoxaluric rat kidneys compared to the control (Fig. 6).
mRNA's of bone morphogenetic proteins BMP2, BMP7, and their re-
ceptor BMPR2 were also increased in both the cortex and medulla of
the treated rats (Fig. 7). Fig. 8 shows results of real time PCR of cytokeratin
8 (KRT8), cytokeratin 18 (KRT18), and Vimentin (VIM) in the cortex and
medulla of the control andHLP fed rats. Expressionof cytokeratin 8mRNA
increased while that of 18 decreased in both cortical and medullary
Fig. 8. Real Time PCR of cytokeratin 8 (KRT8), cytokeratin 18 (KRT18), and Vimentin (VIM) in the cortex and medulla of the control and HLP fed rats. The statistical analyses were per-
formed using GraphPad Prism version 5 for windows (GraphPad software, La Jolla, CA). P-values were calculated using unpaired T-test. P b 0.05 was considered statistically signiﬁcant.
*Control vs. HLP group (P b 0.05), **Control vs. HLP group (P b 0.005), ***Control vs. HLP group (P b 0.0001).
2006 S. Joshi et al. / Biochimica et Biophysica Acta 1852 (2015) 2000–2012tissues. There was many fold increase in VIM mRNA in HLP treated rat
kidneys.
There were many fold increases in mRNA expression for OPN, Fn1,
Col1a1 in both the cortex and medulla of the hyperoxaluric rats com-
pared to the control tissues (Fig. 9). MGPmRNAexpressionwas similar-
ly increased (results not shown).
3.4. Immunohistochemistry
Vimentin is an intermediate ﬁlament expressed mostly in mesen-
chymal cells. Vimentin staining in normal kidneys was limited to the
podocytes and mesangial cells of the glomeruli and endothelium of
the peritubular capillaries in the cortex and vasa recta of the renal me-
dulla (Fig. 10A,B). Tubular epithelia in both cortex and medulla were
generally devoid of vimentin staining. The papillary surface urothelium
of the normal kidneys was also not stained. There was increased
vimentin immunoreactivity in the kidneys of hyperoxaluric rats withCaOx nephrolithiasis. Almost all elements of the kidney including the
renal interstitium and most renal tubules showed vimentin staining.
Strong vimentin expression was seen in tubules that contained CaOx
crystals (Fig. 10C,D). Papillary surface urothelium and both the cortical
andmedullary collecting ducts that did not contain CaOx crystals lacked
vimentin expression.
Pancytokeratin antibody AE1/3 is a cocktail for a number of
cytokeratins found in epithelial cells. No obvious difference was visible
in staining patterns between the kidneys of the control and rats with
CaOx nephrolithiasis (Fig. 10E,F). Glomeruli, endothelium of the
peritubular capillaries and vasa recta and proximal tubules were nega-
tive for pancytokertin. The papillary surface urothelium and epithelia
of the collecting ducts, distal tubules, and thin limbs of the loops of
Henle were generally positively stained.
Fig. 11 shows images of normal and hyperoxaluric kidneys
stained for collagen. In the normal kidneys, Collagen 1 staining was
mostly seen around the large and small blood vessels (Fig. 11A).
Fig. 9. Real time PCR of OPN, Fn1, Col 1a1 and Col 1a2 showing increase in their expressions.
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ticularly around the tubules that contained CaOx crystals. Collagen
stained blue with Masson's trichrome, around the dilated renal tu-
bules that contained CaOx crystals (Fig. 11D). Epithelial cells of
renal tubules without crystals stained red and their nuclei, dark
brown.
Fig. 12 shows staining for OPN, ﬁbronectin and MGP. Normal kid-
neys showed nonspeciﬁc, infrequent and light staining for these
macromolecules (Fig. 12A,C,E). Heavy OPN expressionwasmostly asso-
ciatedwith the crystal deposits (Fig. 12D). Luminal surfaces of the tubu-
lar epithelial cells in contact with the crystals were heavily stained
compared to their lightly stained cytoplasm. Fibronectin staining was
seen in the renal tubular epithelial cells, their lumens as well as
peritubular spaces (Fig. 12F). Matrix gla protein expression was most
pronounced in the medullary peritibular vessels (Fig. 12B) in the kid-
neys of the hyperoxaluric rats. It was also seen associated with CaOx
crystals deposits and the epithelial cells in contact with the crystals.
Normal kidneys showed no staining or non speciﬁc staining of the tubu-
lar contents (Fig. 12A).4. Discussion
It is generally agreed that Randall's plaques, the sub-epithelial de-
posits of CaP on renal papillary surfaces, act as nidi for the development
of at least some idiopathic CaOx kidney stones [10,14,61]. Pathogenesis
of the plaques, where and how do they begin and grow, is however not
well understood. The observations that stone formation and cardiovas-
cular diseases such as hypertension, myocardial infarction, carotid ar-
tery atherosclerosis, coronary heart disease [4,5,62,63], often co-exist
and share risk factors,markers and outcomes have led us to hypothesize
that similar molecules and pathways may be involved in vascular calci-
ﬁcation and RP formation [5,64]. The mechanism of calciﬁcation is
complicated, but results of multiple investigations suggest it to include
a competition between pro- and anti-mineralizing factors. In the
case of vascular calciﬁcation, one of the best studied processes, ﬁrst
step appears to be transformation of vascular smooth cells into an
osteoblast/chondrocyte phenotype [21]. In vitro studies have shown
that exposure of VSMC to elevated levels of calcium and phosphate
[23–26] or uremic toxins such as oxidized proteins, and lipids [65] can
AFE
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B
Fig. 10. Immunohistochemical analyses of the kidneys for vimentin and cytokeratin. A. Normal kidney cortex showing vimentin staining in the glomerulus and peritubular capillaries. B.
Normal kidney papilla showing vimentin staining in the peritubular capillaries. C, D. Strong staining is seen for vimentin in the epithelial cells of the tubules with CaOx crystal deposits as
well as the surrounding renal interstitium. E. Staininingwith pancytokeratin antibody in normal kidney cortex. F. Stainining with pancytokeratin antibody in cortex of a kidney fromHLP-
fed rats. Original Mag ×45.
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high oxalate and CaOx crystals can similarly trigger epithelial to osteo-
blast transformation. But it alone cannot explain the formation of
Randall's plaques, which are common even in non-stone formers [10,
12]. There is the possibility of other instigators and situations, such as
reduction in crystallization inhibitory capacity as shown in THP null
mice [66]. Lack of overt inﬂammation around the plaqueswould also in-
dicate malfunctioning crystal clearance system. Experimental studies
have shown that crystals, CaOx aswell as CaP, provoke inﬂammatory re-
sponses, attract monocytes and macrophages which surround the crys-
tals and eventually dispose of them [67–70].
Previous in vitro cell culture and in vivo animalmodel studies have al-
ready shown that renal epithelial cells react to the presence of high oxa-
late and CaOx/CaP crystals [71–76]. The response is probably mediated
by the production of reactive oxygen species [77,78] through mitochon-
dria [79–82] or NADPHoxidase [57,83,84] involvement and characterized
by altered expression of speciﬁc genes encoding for transcriptional activa-
tors, regulators of the extracellularmatrix, and growth factors [85,86]. The
production of pro and anti-inﬂammatory molecule, including OPN,
Tamm–Horsfall protein, monocyte chemoattractant-1 (MCP-1), prosta-
glandin E2 (PGE2), bikunin and other components of inter-α-inhibitor
(IαI), α-1 microglobulin, CD-44, calgranulin, heparin sulfate, fetuin,
osteonectin, ﬁbronectin and matrix-gla-protein (MGP) is modiﬁed [60,
71,87]. Genes encoding for ﬁbronectin, CD-44, fetuin B, osteopontin, and
matrix-gla protein, are up-regulated while those encoding for heavychains of inter-alpha-inhibitor 1, 3 and 4, calgranulin B, prothrombin,
and Tamm–Horsfall protein were down-regulated [88]. Gene expression
of vimentin, a mesenchymal marker, is also increased [89].
Interestingly, the inﬂammatory molecules altered during CaOx
nephrolithiasis and epithelial exposure to oxalate and CaOx crystals
[71,87,88], are also integral to the calciﬁcation cascade during both the
physiological and pathological processes [49]. Production of OPN, FN,
MGP, and collagens are indicators of osteoblastic character of the cells.
Results presented here show up-regulation of genes for OPN, FN, MGP
and collagens and their increased expression in the kidneys of
hyperoxaluric rats indicate transformation of cells from their normal
epithelial phenotype to osteoblast.
Transformation of vascular smooth cells into an osteoblast/chondro-
cyte phenotype is brought about through the upregulation of RUNX2
induced by multiple risk factors including oxidative stress and inﬂam-
mation [90]. RUNX2 is consideredmaster transcription factor for osteo-
blast differentiation and matrix production while Osterix works
downstream of RUNX2 [53]. RUNX1 also appears to be involved in oste-
ogenesis andworks in co-operationwith RUNX2 [91]. In our study, both
genome wide analyses and RT-PCR showed that genes responsible for
these three transcription factors were upregulated in kidneys of the
hyperoxaluric rats.
Bonemorphogenetic proteins 2–7 (BMP2-7) belong to transforming
growth factor beta superfamily of growth factors and interact with spe-
ciﬁc receptors, BMPRs on the cell surfaces. BMP2 and BMP7 interact
BC D
A
Fig. 11. Immunohistochemical analyses of the kidneys of control and HLP-fed rats for collagen. A In normal Collagen 1 expression is mostly limited to areas around large and small blood
vessels. OriginalMag×10. B. C. In hyperoxaluric kidneys Collagen 1 expression is interstitial andmore intense around tubuleswith CaOx crystal deposits. Crystals have been lost during the
processing. D. Collagen stained blue withMason's trichrome. There is strong staining around the tubules with CaOx crystal deposits. Epithelial cells of the tubules without crystals stained
red. Original Mag ×45.
2009S. Joshi et al. / Biochimica et Biophysica Acta 1852 (2015) 2000–2012with BMPR2 and are involved in a variety of cellular functions including
osteoblast differentiation [46,47]. RUNX2 is a common target of BMP2
[92,93]. Results of our study show upregulation of BMP2, BMP7 as
well as BMPR2 genes in the kidneys of hyperoxaluric rats. BMP2 induces
OPN expression through RUNX2 [93]. RUNX2 is also involved in tran-
scriptional regulation ofmany other proteins involved inmineralization
such asmatrix-GLAprotein (MGP) [94], collagen1a1 [95,96], osteocalcin
[97], and ﬁbronectin [92]. BMP2 and RUNX2 induced calciﬁcation is
modulated through NADPH oxidase mediated production of reactive
oxygen species [29,98].
Whether oxalate or CaOx crystals were responsible for altered ex-
pressions is difﬁcult to say in thismodel. However, expression of various
genes studied, was higher in themedulla than in the cortex while more
crystals were seen in the cortex than in the medulla.
Demonstration of increased gene and protein expression of OPN, FN
andMGP in animal model of CaOx nephrolithiasis and cell culture stud-
ies is not new. However, upregulation of genes encoding for RUNX1 and
2, Osterix, BMP2 and 7, BMPr2 and Col1a1 and 2 in response to oxalate
and/or CaOx crystal exposures and transformation of renal epithelial
cells into osteoblast has not been previously reported. A recent study
has however, shown high basal levels of BMP2, RUNX2, and Osterix in
kidneys of genetic hypercalciuric rat kidneys with intratubular calcium
phosphate deposits [99]. Vitamin D receptor (VDR) knockdown in the
rats reduced the expression levels of BMP2, RUNX2, and Osterix as
well as CaP crystal deposition in the kidneys. Authors concluded that
VDR might be a signiﬁcant regulator of nephrocalcinosis in genetic hy-
percalciuric rats.
Our investigations demonstrate upregulation ofmany key osteogen-
ic genes and proteins involved in calciﬁcation, and downregulation of
epithelial markers, indicating that renal epithelial cells in hyperoxaluric
conditions lose their epithelial phenotype and acquire characteristic
features of osteoblasts. That epithelial cells transform into other celltypes is well known. Epithelial to mesenchymal transformation is
known to play a role in renal ﬁbrosis [100] and mesenchymal stem
cells are known to promote calciﬁcation [101]. But we did not ﬁnd any
calcium phosphate deposition, intratubular or interstitial, in the kidneys
of the hyperoxaluric rats. Actually, none of the experimental rat or mice
models of hyperoxaluria have ever reported calcium phosphate crystal
deposition in the kidneys [102,103]. Our study also showed downregu-
lation of alkaline phosphatase and upregulation of calciﬁcation inhibi-
tors, OPN and MGP. We deduce that lack of calcium phosphate
deposition in the kidneys is related to decrease in the production of
alkaline phosphatase which hydrolyses pyrophosphate to provide inor-
ganic phosphate for the formation of CaP crystals. Increased production
of OPN andMGP, key inhibitors of crystal formationmay also play a role.
We postulate that pathogenesis of kidney stones involves renal tubular
epithelial cells becoming osteogenic and production and activation of
alkaline phosphatase. Deposition of CaP in the renal tubules will lead
to the formation of Randall's plugs. Transcytosis of intratubular CaP
crystals from the apical to the basal aspect of the epithelium will lead
to the formation of Randall's plaques [72,104]. Both plugs and plaques
can act as nidi for the formation of CaOx kidney stones [10,14].
Results of our studies indicate the possibility of tubular cells acquir-
ing an osteoblast phenotype after a metabolic stimulus. Despite the os-
teogenic transformation of the epithelial cells, apatite deposition was
not observed indicating the necessity of additional stimuli, alterations,
or perhaps involvement of the elements of vascular system [62]. It
should also be pointed out that animal models have limitations [102,
103]. For example rats andmice have unipapillate kidneys;maymetab-
olize oxalate differently; and compared to humans, normally excrete
very high amounts of oxalate in the urine, without CaOx crystalluria
or crystal deposition in the kidneys. Rats and mice appear to possess
protective capabilities. Downregulation of alkaline phosphatase seen
in this model may be one such response.
A B
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Fig. 12. Immunohistochemical analyses of the kidneys of control (A, C, E) and HLP-fed rats (B, D, F) forMGP, OPN and ﬁbronectin. A. Only nonspeciﬁc staining forMGPwas seen (arrow) in
normal rat kidneys. B. MGP staining wasmarkedly increased in the peritubular vessels (arrows) of the kidneys of hyperoxaluric rats (arrows). C. OPN staining was not seen in the normal
kidneys except on the papillary urothelial surface (not shown). D. Staining of epithelial cells for osteopontin wasmostly associatedwith crystal deposits (arrows). E. Diffuse light staining
forﬁbronectin is seen in renal epithelial cells aswell interstitiumof the normal kidneys. F. Intenseﬁbronectin staining is seen in both the tubular epithelial cells aswell as interstitiumof the
kidneys with hyperoxaluria. Original Mag ×45.
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Present study represents the ﬁrst robust demonstration of the possi-
ble evolution of tubular cells to osteoblast-like cells. We conclude that
hyperoxaluria can induce epithelial cells to acquire a number of osteo-
blastic characteristics. But those changes are not sufﬁcient to produce
deposition of calcium phosphate, whichmay require additional changes
including localized increase in calcium and phosphate and decrease in
mineralization inhibitory potential.
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